The role of CD4+ T cell responses in antitumor immunity
Open Access
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 10 (5) , 588-594
- https://doi.org/10.1016/s0952-7915(98)80228-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- CD4+Hepatic Cancer-Specific Cytotoxic T Lymphocytes in Patients with Hepatocellular CarcinomaCellular Immunology, 1997
- Interactions between Autologous CD4+and CD8+T Lymphocytes and Human Squamous Cell Carcinoma of the Head and NeckCellular Immunology, 1997
- T cells recognize the VH complementarity‐determining region 3 of the idiotypic protein of B cell non‐Hodgkin's lymphomaEuropean Journal of Immunology, 1997
- Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.The Journal of Experimental Medicine, 1996
- A unique tumor antigen produced by a single amino acid substitutionImmunity, 1995
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.The Journal of Experimental Medicine, 1994
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990